- Investing Ideas
- /
- U.S. Financially Fit Penny Stocks
U.S. Financially Fit Penny Stocks
Results
723
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
723 companies
AC Immune
Market Cap: US$169.2m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$1.71
7D
4.9%
1Y
-45.9%
Talphera
Market Cap: US$8.6m
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
TLPH
US$0.50
7D
-3.4%
1Y
-53.3%
Organic Agricultural
Market Cap: US$18.5k
Through its subsidiaries, processes and sells food products in the People's Republic of China.
OGAA
US$0.0002
7D
0%
1Y
-99.6%
PodcastOne
Market Cap: US$50.3m
Operates as a podcast platform and publisher.
PODC
US$2.02
7D
8.0%
1Y
14.8%
Jowell Global
Market Cap: US$4.8m
Engages in the online retail of cosmetics, health and nutritional supplements, and household products in China.
JWEL
US$2.21
7D
-6.0%
1Y
95.5%
Corvus Pharmaceuticals
Market Cap: US$246.0m
A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.
CRVS
US$3.61
7D
-11.0%
1Y
58.3%
Chemomab Therapeutics
Market Cap: US$25.8m
A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.
CMMB
US$1.37
7D
10.5%
1Y
59.3%
C4 Therapeutics
Market Cap: US$98.0m
A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.
CCCC
US$1.38
7D
-12.7%
1Y
-75.4%
PDS Biotechnology
Market Cap: US$64.5m
A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.
PDSB
US$1.42
7D
10.1%
1Y
-58.0%
DallasNews
Market Cap: US$23.6m
DallasNews Corporation, together with its subsidiaries, publishes and sells newspapers in Texas.
DALN
US$4.41
7D
1.6%
1Y
16.1%
Airgain
Market Cap: US$49.4m
Provides wireless connectivity solutions that offers embedded components, external antennas, and integrated systems worldwide.
AIRG
US$4.19
7D
9.7%
1Y
-17.8%
Altamira Therapeutics
Market Cap: US$571.5k
Operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe.
CYTO.F
US$0.10
7D
40.8%
1Y
-93.3%
Jupai Holdings
Market Cap: US$286.6k
Provides wealth management products and advisory services to high-net-worth individuals in China.
JPPY.Y
US$0.009
7D
4,400.0%
1Y
-87.3%
Integrated BioPharma
Market Cap: US$10.3m
Engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg.
INBP
US$0.34
7D
32.7%
1Y
54.5%
Gaxos.ai
Market Cap: US$9.4m
Engages in developing artificial intelligence applications.
GXAI
US$1.32
7D
0.8%
1Y
-65.3%
Kopin
Market Cap: US$232.2m
Kopin Corporation, together with its subsidiaries, invents, develops, manufactures, and sells microdisplays, subassemblies, and related components for defense, enterprise, industrial, and consumer products in the United States, the Asia-Pacific, Europe, and internationally.
KOPN
US$1.48
7D
-4.5%
1Y
76.6%
NeuroOne Medical Technologies
Market Cap: US$31.5m
A medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
NMTC
US$0.67
7D
6.8%
1Y
-36.7%
Zura Bio
Market Cap: US$68.7m
A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.
ZURA
US$1.11
7D
-10.5%
1Y
-81.5%
SES AI
Market Cap: US$343.5m
Engages in the development and production of AI enhanced lithium metal and lithium ion rechargeable battery technologies for electric vehicles, urban air mobility, drones, robotics, battery energy storage systems, and other applications in the United States and the Asia Pacific region.
SES
US$0.94
7D
2.9%
1Y
-29.1%
Calima Energy
Market Cap: US$5.7m
A production-focused energy company, explores for and develops oil and natural gas assets in the Western Canadian Sedimentary Basin.
CLME.F
US$0.013
7D
0%
1Y
n/a
PLAYSTUDIOS
Market Cap: US$186.4m
Develops and publishes free-to-play casual games for mobile and social platforms in the United States and internationally.
MYPS
US$1.49
7D
-10.2%
1Y
-33.8%
Trio-Tech International
Market Cap: US$21.0m
Offers manufacturing, testing, and distribution services to the semiconductor industry in the United States, Singapore, Malaysia, Thailand, and China.
TRT
US$4.95
7D
-6.6%
1Y
-25.0%
Aytu BioPharma
Market Cap: US$13.1m
A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.
AYTU
US$2.13
7D
71.8%
1Y
-30.8%
Kid Castle Educational
Market Cap: US$8.9k
Operates and manages a portfolio of real estate properties, digital assets, and other in-demand properties in the United States.
KDCE
US$0.0004
7D
0%
1Y
n/a
Innovative Eyewear
Market Cap: US$6.9m
Engages in the development and sale of smart eyeglasses and sunglasses in North America.
LUCY
US$2.80
7D
49.7%
1Y
-25.9%
Perspective Therapeutics
Market Cap: US$195.2m
Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.
CATX
US$2.63
7D
4.8%
1Y
-83.9%
Mastermind
Market Cap: US$921.3k
An involvement marketing service agency, designs, creates, and develops branding and marketing campaigns for corporate clients.
MMND
US$0.027
7D
-22.7%
1Y
-56.1%
BioRestorative Therapies
Market Cap: US$12.1m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.61
7D
-12.7%
1Y
24.8%
Intrusion
Market Cap: US$34.6m
Operates as a cybersecurity company in the United States.
INTZ
US$1.74
7D
10.8%
1Y
7.4%
Silo Pharma
Market Cap: US$3.8m
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.
SILO
US$0.48
7D
-54.8%
1Y
-76.2%
Compass Therapeutics
Market Cap: US$290.4m
A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.
CMPX
US$2.10
7D
15.4%
1Y
31.3%
Bon Natural Life
Market Cap: US$6.7m
Engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People’s Republic of China and internationally.
BON
US$1.60
7D
14.7%
1Y
-97.5%
SelectQuote
Market Cap: US$395.5m
Operates a technology-enabled, direct-to-consumer distribution platform that sells insurance policies and healthcare services in the United States.
SLQT
US$2.29
7D
-2.6%
1Y
-17.3%
Fortitude Gold
Market Cap: US$76.4m
Operates as a mining company that explores for gold and silver projects in the United States.
FTCO
US$3.16
7D
5.7%
1Y
-36.3%
Pixelworks
Market Cap: US$34.1m
Develops and markets semiconductor and software solutions for mobile, home and enterprise, and cinema markets in the United States, Japan, China, Taiwan, Korea, and Europe.
PXLW
US$0.54
7D
-5.1%
1Y
-49.9%
Hyliion Holdings
Market Cap: US$241.8m
Designs and develops power generators for stationary and mobile applications.
HYLN
US$1.38
7D
-22.9%
1Y
-8.0%